Once-daily indacaterol as effective as salmeterol bid for COPD
www.pulmccm.org
The once-daily beta-agonist was better than placebo and at least as good as twice-daily salmeterol, as measured by the SGRQ, TDI, and FEV1 after 12 weeks. The drug previously matched up well against tiotropium. Indacaterol is available in Europe, but not in the U.S.
Once-daily indacaterol as effective as salmeterol bid for COPD
Once-daily indacaterol as effective as…
Once-daily indacaterol as effective as salmeterol bid for COPD
The once-daily beta-agonist was better than placebo and at least as good as twice-daily salmeterol, as measured by the SGRQ, TDI, and FEV1 after 12 weeks. The drug previously matched up well against tiotropium. Indacaterol is available in Europe, but not in the U.S.